Generated: October 21, 2017
DrugPatentWatch Database Preview
Details for Patent: 5,854,270
Summary for Patent: 5,854,270
|Title:|| Oral compositions containing ondansetron|
|Abstract:||The invention relates to a liquid composition for oral administration comprising ondansetron or a pharmaceutically acceptable derivative thereof, a sweetener and one or more pharmaceutically acceptable excipients. The sweetener comprises one or more polyhydric alcohols and the pH of the combination lies in the range 2.0 to 5.0. Methods for the manufacture of such compositions and for their use in the treatment of conditions mediated through the action of 5-hydroxytryptamine (5 HT) at 5 HT.sub.3 receptors are also included.|
|Inventor(s):|| Gambhir; Renu (Mississauga, CA) |
|Assignee:|| Glaxo Wellcome Inc. (Mississauga, CA) |
Patent Claim Types:|
see list of patent claims
|Composition; Dosage form; Use; |
No matches for this query
Foreign Priority and PCT Information for Patent: 5,854,270
|Foriegn Application Priority Data|
||Foreign Patent Number
||Foreign Patent Date
|United Kingdom||9423588||Nov 22, 1994|
|PCT Filed||November 20, 1995||PCT Application Number:||PCT/IB95/01152|
|PCT Publication Date:||May 30, 1996||PCT Publication Number:||
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.